iShares Genomics Immunology and Healthcare ETF
$30.112.69 %$IDNA
About iShares Genomics Immunology and Healthcare ETF (IDNA)
iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund established on June 11, 2019 and traded on the NYSE exchange. The fund manages approximately $0.15 billion in net assets, making it a significant ETF in its category.
With an expense ratio of 0.47%, iShares Genomics Immunology and Healthcare ETF is considered a low-cost investment option for investors seeking exposure to this asset class.
The fund currently offers a dividend yield of 0.51%, providing income-seeking investors with supplemental distributions alongside potential capital appreciation.
What You Need to Know About IDNA
- Inception Date: June 11, 2019 - providing 6 years of track record
- Assets Under Management: $0.15 billion in net assets
- Expense Ratio: 0.47% annually
- Dividend Yield: 0.51% annual yield
- Exchange: NYSE
- Type: Traditional ETF
Compare IDNA with other investment options: ETF Screener | Stock Screener
Price History
▲+3.37%
Fund Details
Dividend Yield0.51%
Inception Date2019-06-11
Net Assets$150.2M
Net Expense Ratio0.00%